4SC Discovery Articles
LEO Pharma and 4SC Discovery link for skin disease research
26 February 2013
4SC Discovery and BioNTech enter cancer therapy research partnership
21 February 2013
Showing 1-2 of 2 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
